sign up for retatrutide trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Triple hormone receptor agonist retatrutide
Description
The differentiator is pathway-level genetic insight context that most telehealth-only programs like Midi Health do not offer alongside the medication itself

Practical and concise guidance for prescribers and patients for the administration and storage of medications

Supplementary information, Fig

Eli Lilly has made it accessible through multiple channels including LillyDirect, telehealth providers, and retail pharmacies nationwide so getting started doesn't require an in-person visit
This detailed guide explains the expected benefits, risks, and what patients in the UK should know before considering future treatment options